To learn more about cancer-associated fibroblasts (CAFs), we have isolated fibroblasts from different stages of breast cancer progression and analysed their function and gene expression. These analyses reveal that activation of the YAP transcription factor is a signature feature of CAFs. YAP function is required for CAFs to promote matrix stiffening, cancer cell invasion and angiogenesis. Remodelling of the ECM and promotion of cancer cell invasion requires the actomyosin cytoskeleton. YAP regulates the expression of several cytoskeletal regulators, including ANLN and DIAPH3, and controls the protein levels of MYL9 (also known as MLC2). Matrix stiffening further enhances YAP activation, thus establishing a feed-forward self-reinforcing loop that helps to maintain the CAF phenotype. Actomyosin contractility and Src function are required for YAP activation by stiff matrices. Further, transient ROCK inhibition is able to disrupt the feed-forward loop, leading to a long-lasting reversion of the CAF phenotype.
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts To learn more about cancer-associated fibroblasts (CAFs), we have isolated fibroblasts from different stages of breast cancer progression and analysed their function and gene expression. These analyses reveal that activation of the YAP transcription factor is a signature feature of CAFs. YAP function is required for CAFs to promote matrix stiffening, cancer cell invasion and angiogenesis. Remodelling of the ECM and promotion of cancer cell invasion requires the actomyosin cytoskeleton. YAP regulates the expression of several cytoskeletal regulators, including ANLN and DIAPH3, and controls the protein levels of MYL9 (also known as MLC2). Matrix stiffening further enhances YAP activation, thus establishing a feed-forward self-reinforcing loop that helps to maintain the CAF phenotype. Actomyosin contractility and Src function are required for YAP activation by stiff matrices. Further, transient ROCK inhibition is able to disrupt the feed-forward loop, leading to a long-lasting reversion of the CAF phenotype.
Tumours contain a complex mixture of cell types and matrix components 1, 2 . Non-cancerous cells and matricellular molecules within the tumour can promote dissemination 3 . In addition, the physical characteristics of the extracellular matrix (ECM) enhance invasion and metastasis [4] [5] [6] [7] [8] . Increased matrix stiffness is a feature of most solid tumours 9 . Matrix stiffness can be sensed by many cell types. Force exerted on integrin-mediated adhesions can lead to the activation of FAK, Src family kinases and RhoA (refs 7,10,11) . More recently, it has been shown that stiff matrices promote the activity of the YAP and TAZ transcriptional regulators 12 . Elevated YAP and TAZ function is associated with increased cancer stem cell properties and metastasis 13, 14 . These observations help to explain how matrix stiffness might be linked to more aggressive tumour phenotypes. However, the interplay between the tumour stroma and matrix stiffness is not well understood.
CAFs are found in many solid tumours, including breast and squamous cell carcinoma (SCC), and promote invasion and metastasis through the production of soluble factors and matrix remodelling 15 . In some cases, matrix remodelling leads to the generation of tracks through the ECM that enable subsequent cancer cell invasion 6 . Markers such as α-smooth muscle actin (αSMA) and S100A4 (also known as FSP1) are associated with CAFs; however, they are often not specific for CAFs and may not relate directly to the functional properties of CAFs (ref. 16 ). This has hampered understanding of the pro-tumorigenic signals in the stroma that are required to generate and maintain CAFs. In this study, we uncover a positive feedback loop involving YAP function and matrix stiffening that is critical for the function of CAFs.
RESULTS

Characterization of fibroblasts from different stages of mammary tumour progression
To learn more about CAFs we isolated fibroblasts from normal mouse mammary glands and hyperplastic tissue, mammary adenoma and mammary carcinoma in mice containing the MMTV-PyMT transgene 17 ( Supplementary Fig. S1a ). This model was chosen because it contains a fibroblastic stroma with an increased density of collagen fibres ( Supplementary Fig. S1b ), and its progression can be modulated by genetic manipulation of fibroblasts 18, 19 . To facilitate further experiments, the fibroblasts we isolated were immortalized using human papilloma virus (HPV)-E6 (ref. 20) . In total we isolated three Vimentin αSMA (h) Quantification of 4T1 invasion into matrices previously remodelled by different fibroblasts. Bars represent mean ± s.e.m. n = organotypic assays (-, 4; NF, 18; HpAF, 5; AdAF, 6; CAF, 24), assessed over multiple experiments (-, 2; NF, 4; HpAF, 2; AdAF, 2; CAF, 6). (i) Quantification of 4T1 invasion when co-cultured with different fibroblasts. Bars represent mean ± s.e.m. n = organotypic assays (-, 29; NF, 53; HpAF, 19; AdAF, 22; CAF, 56), assessed over multiple experiments (-, 6; NF, 12; HpAF, 4; AdAF, 5; CAF, 12). (j) Images show endomucin and vimentin staining of matrix plugs with or without different fibroblasts injected subcutaneously in mice. Scale bar, 50 µm. Graph shows quantification of endomucin staining relative to fibroblast number (vimentin staining). Each data point represents a different plug (NF, n = 7; CAF, n = 16). * P < 0.05; * * * P < 0.001, unpaired t -test. Uncropped images of blots are shown in Supplementary Fig. S6 . sets of normal mammary fibroblasts (NFs), two hyperplasia-associated fibroblasts (HpAFs), two adenoma-associated fibroblasts (AdAFs) and four sets of CAFs. The multi-focal nature of the PyMT model 17, 21 enabled us to establish a hyperplasia-, an adenoma-and a carcinomaassociated fibroblast line from different regions of the same mouse; these were designated HpAF#1, AdAF#1 and CAF#1. We confirmed that they were positive for the expected fibroblast markers (Fig. 1a ). Expression of CAF markers, αSMA and S100A4, was increased in the fibroblasts isolated from adenoma and carcinoma ( Fig. 1b) . Quantification revealed increased αSMA levels in all four CAF isolates, fibroblast-activation protein (FAP) levels were highest in CAF#1 and CAF#2, whereas S100A4 was elevated in CAF#1 and CAF#4 ( Supplementary Fig. S2c ). At the single-cell level there was significant heterogeneity in the expression of αSMA, S100A4 and FAP, both in vivo and in vitro: not all fibroblasts in tumours were αSMA positive, and various combinations of αSMA, S100A4 and FAP positivity were observed (Supplementary Figs S1b and S2d). Similar results were obtained with the human SCC CAF lines CerCAF (cervical SCC CAF), HNCAF (head and neck SCC CAF) and VCAF (vulval SCC CAF; Supplementary Fig. S2e ). Thus, the diversity of CAF marker expression 16 is represented in the CAFs that we isolated ( Supplementary  Fig. S2f ). CAFs exhibited cytoskeletal changes that suggested increased isometric tension. They had more pronounced stress fibres, more focal adhesions and increased fibronectin fibrillogenesis ( Fig. 1c ). Myosin light chain 2 (MYL9, also known as MLC2) phosphorylation and total protein levels were strongly increased in AdAF#1 and CAF#1, and several other proteins implicated in cytoskeletal regulation (MYH9, MYH10 and DIAPH1) were modestly upregulated in AdAF#1 and CAF#1 ( Fig. 1d ). More significantly, the ability of the fibroblasts to contract collagen gels, a measure of their matrix remodelling capacity, increased with disease stage ( Fig. 1e and Supplementary Fig.  S2a ). Cancer cells were unable to remodel the matrices. Contraction of the gels by CAFs was associated with the appearance of thicker collagen fibres (upper panels Fig. 1f ), and an eightfold increase in the stiffness of the matrix from ∼120 Pa to >1 kPa ( Fig. 1f ). This is highly consistent with the change in tissue stiffness observed between normal mammary tissue and tumours 9 . We next investigated whether CAF-remodelled matrices were rendered permissive for the invasion of breast cancer cells. Fibroblasts were allowed to remodel the matrix for five days before being killed. The ability of cancer cells to invade into these matrices was then evaluated. CAF#1 and, to a lesser extent, AdAF#1 were able to promote cancer cell invasion ( Fig. 1g,h ). NFs and HpAFs did not generate matrices permissive for invasion. Similarly, in organotypic co-culture models, CAFs were the most effective at promoting the invasion of breast cancer cells ( Fig. 1i and Supplementary Fig. S2b ). These results were confirmed using the syngeneic breast cancer cell line MMTV-PyMT TS2 (ref. 22 and Supplementary Fig. S1c ). Finally, we demonstrated that CAFs were able to promote angiogenesis in the absence of any cancer cells in vivo ( Fig. 1j ; endomucin stains endothelial cells, vimentin stains fibroblasts). These data demonstrate the successful isolation of fibroblasts from different stages of a murine breast cancer model. Further, we show that their matrix-remodelling-and invasion-promoting abilities increase with the disease stage.
YAP is activated in CAFs
We then performed global messenger RNA analysis on the fibroblasts isolated from different disease stages. RNA samples were prepared from the fibroblasts cultured on the collagen-rich matrices used for the functional assays. Gene set enrichment analysis 23 (GSEA) was performed to identify changes in coordinated gene expression programs ( Supplementary Table S1 ). Strikingly, we noted that the genes upregulated in our murine CAFs showed significant overlap with gene expression in the stroma of human breast cancer with poor prognosis 24, 25 ( Supplementary Fig. S3a ). These observations suggest that our experimental system is likely to have significant relevance for human disease. As expected, GSEA revealed changes in inflammatory signalling [26] [27] [28] , although these changes were typically more pronounced in HpAFs and AdAFs ( Supplementary Table S1 ). We also noted significantly increased expression of genes associated with two mechano-sensitive pathways, YAP/TAZ (refs 12,29-31; Table 1 and Supplementary Fig. S2b ) and SRF (refs 32-34 and Supplementary  Table S1 ). We chose to investigate whether YAP or TAZ, closely related paralogues, were involved in CAF function. YAP/TAZ are negatively regulated by phosphorylation by LATS1&2, which are in turn regulated by MST1&2 (refs 35,36) . Phosphorylation of YAP and TAZ is associated with their sequestration in the cytoplasm 37 . Reduced MST1/2 and LATS1/2 activity leads to nuclear accumulation, binding to TEAD and other proteins, and activation of transcription. YAP activation is well known to be oncogenic within epithelial cells 35 , but its role in the tumour stroma has not been explored. Recently, YAP/TAZ activation has been reported in response to mechanical stress and perturbation of the actin cytoskeleton 12, [38] [39] [40] [41] . Figure 2a shows that YAP is predominantly cytoplasmic in NFs but accumulates in the nucleus in CAFs; HpAFs and AdAFs show intermediate levels of nuclear YAP (alternative quantification of the percentage of cells with predominantly nuclear YAP is shown in Supplementary  Fig. S3c ). Nuclear localization of YAP was a universal feature of CAFs, regardless of their expression levels of αSMA, FAP or S100A4 ( Supplementary Fig. S3d , also compare Supplementary Figs S2c and S3c). The localization of TAZ showed more subtle differences between normal mammary fibroblasts and CAFs ( Fig. 2a ). Interestingly, the activity of the upstream negative regulators, MST1/2, was not different between NFs and CAFs. Further, the activity of LATS kinases and phosphorylation of Ser 127 on YAP was even elevated in CAFs ( Fig. 2c ). Together, these data argue that YAP is not activated by reduced activity of the canonical MST1/2-LATS pathways in CAFs. Instead, YAP is regulated at the level of interaction with TEAD and 14-3-3 proteins. In NFs, YAP interacted strongly with 14-3-3 proteins, but it switched to interacting with TEAD1 and TEAD4 transcription factors in CAFs (Fig. 2d ). This switch in binding partners correlated with increasing Tyr 357 phosphorylation of YAP (ref. 42 and Fig. 2c ). We confirmed that YAP was indeed transcriptionally active in CAFs by monitoring the expression of 4 endogenous YAP/TAZ target genes in two different CAF lines. Figure 2e and Supplementary Fig.  S3e show a consistent pattern of activation of YAP target genes in CAFs ( Supplementary Fig. S3f confirms these genes as YAP targets). Histochemical analysis of the normal murine mammary tissue and PyMT-driven tumours revealed nuclear accumulation of YAP in the stroma of large adenoma and carcinoma lesions ( Fig. 2f ). In advanced carcinoma lesions, YAP activation in the stroma was further enhanced in the tumoral margins. Moreover, human breast cancer and SCC biopsies showed nuclear accumulation of YAP in stromal fibroblasts ( Fig. 3a,b ). YAP/TAZ activation was maintained in three different isolates of human SCC CAFs (Fig. 3c,d) . 
YAP is required for CAF function
We next investigated whether YAP or TAZ function was important for the functional properties of CAFs. Depletion of YAP with three different short interfering RNAs (siRNAs) reduced the ability of the CAFs to physically contract collagen-rich matrices (Fig. 4a ). YAP-depleted cells also had fewer focal adhesions, essential structures for force transmission between the cytoskeleton and matrix (Fig. 4b ). These defects were associated with fewer thick collagen fibres within matrices containing YAP-depleted cells together with a lower elastic modulus ( Fig. 4c ). In contrast, depletion of TAZ had little effect ( Fig. 4a,b ). The ability of CAFs to promote cancer cell invasion was also significantly dependent on YAP function, but TAZ was not required ( Fig. 4d and Supplementary Fig. S4a ). We confirmed these observations in three different human CAF lines derived from SCC ( Fig. 4e ). Depletion of YAP also reduced the ability of CAFs to form fibrous collagen networks and promote angiogenesis in vivo ( Fig. 4f -Masson's trichrome and endomucin staining, respectively). Conversely, activation of YAP signalling by either overexpression of an active mutant or depletion of MST1&2 increased invasion-promoting ability of NFs ( Supplementary  Fig. S4b ,g). Together, these data demonstrate that YAP is critical for many aspects of the tumour-promoting function of CAFs.
YAP regulates the contractile actomyosin cytoskeleton
We then sought to identify YAP-regulated genes that were required for matrix remodelling by CAFs. We focused on 14 genes that our microarray analysis had indicated were upregulated in CAFs (see Fig. 2e and Supplementary Fig. S3e for validation of specific genes) and had been implicated as YAP targets in genomic analyses 29, 30 . We also tested DIAPH1 and MYL9 because we had noted their elevated protein levels in CAFs (Fig. 1d ). Figure 5a shows the effect of YAP siRNA on the mRNA expression levels of the indicated genes (based on YAP siRNA in CAF#1, CAF#2, CerCAF, HNCAF and VCAF). This revealed that 6 out of the 14 genes with elevated mRNA levels in CAFs were found to be consistently transcriptionally regulated by YAP (AMOTL2, ANKRD1, ANLN, CTGF, DIAPH3 and SDPR).
Others were YAP targets in the minority of the five CAF isolates that we tested (DIAPH1, FLNA and THBS1). MYL9 and MYH10 were not transcriptionally regulated by YAP. Amongst these genes, we identified several that are required for CAF-driven matrix remodelling and invasion ( Fig. 5b ,c; see Supplementary Fig. S4c for knockdown efficiency). Significantly, ANLN, DIAPH3 and FLNA were required for CAFs to both remodel the ECM and promote invasion ( Fig. 5b ,c, invasion data shown with multiple siRNA in Supplementary Fig. S4d ). This establishes a role for at least two YAP transcriptional targets in 
Ctr siRNA YAP siRNA * * * * * * * * * * * * * * * * * Supplementary Table S2 (Statistics Source Data). Uncropped images of blots are shown in Supplementary Fig. S6 . enabling the CAF phenotype. This is in agreement with previous reports showing YAP and TEAD binding to the ANLN promoter 30 . We also found that MYL9 and MYH10 are required for CAF functionality (Fig. 5b ,c and see Supplementary Fig. S4e for multiple siRNA). These genes are not transcriptionally regulated by YAP; nonetheless we explored whether their protein levels depend on YAP. Figure 5d shows that depletion of YAP, but not TAZ, reduces both the total levels of MYL9 and MYH10 and the level of active Ser 19 phosphorylated MYL9. Similar data were obtained in CAF#2 and human vulval SCC CAFs ( Supplementary Fig. S4f ). The critical importance of MYL9 for CAF function was confirmed by overexpressing either wild-type MYL9 or an inactive mutant in NFs. Only wild-type MYL9 overexpression resulted in a gain of matrix-remodelling-and invasion-promoting functions (Fig. 5e,f) . Finally, blockade of MYL9 function (using blebbistatin) reduced matrix remodelling by CAFs (Fig. 5g ). Together, these data establish regulation of MYL9 by YAP as a critical factor for generating CAFs with matrix-remodelling-and invasion-promoting abilities.
A positive feedback loop involving actomyosin contractility sustains YAP activation
To understand what drives YAP activation in CAFs, we investigated how YAP activity was induced in normal fibroblasts. Conditioned media from cancer cells promotes matrix remodelling by normal fibroblasts (Fig. 6a ) and increases their ability to support cancer cell CAF#2 CerCAF HNCAF * * * * * * * * invasion ( Supplementary Fig. S5a-c ). This change in behaviour was also associated with the nuclear translocation of YAP and the activation of some YAP/TAZ target genes (Fig. 6b,c) . The degree of YAP nuclear localization triggered by conditioned media, and the range of target genes activated was less extensive than in CAFs (compare Figs 2  and 6b,c) . We also noted that other pro-contractile stimuli, such as l-α-lysophosphatidic acid (LPA) and transforming growth factor-β (TGF-β), promoted nuclear accumulation of YAP (Fig. 6a,b ). YAP can respond to matrix stiffness 12 ; therefore, the ability of soluble factors to activate YAP could be the indirect result of their ability to promote matrix remodelling and concomitant stiffening. Such a mechanism of YAP activation would be reduced by blockade of matrix remodelling. We prevented matrix remodelling by chronically blocking actomyosin function (using blebbistatin). Actomyosin inhibition blocked the matrix remodelling and nuclear accumulation of YAP induced by conditioned media, TGF-β and LPA (Fig. 6a,b) . These data show that YAP can be activated by various soluble factors; however the mechanism may be indirect because a functional contractile cytoskeleton is required in all cases. We next focused on the high steady-state level of YAP signalling in CAFs. This elevated level of YAP signalling could be prevented if the stiffening of the ECM was blocked. Figure 6d shows that ROCK inhibition reduces the elastic modulus of matrices containing CAFs from >500 Pa to ∼100 Pa. This is associated with reduced nuclear localization of YAP and reduced expression of several, but not all, YAP target genes (Fig. 6e,f) . Similar results were obtained if actomyosin function was blocked using blebbistatin. Finally, we confirmed previous findings 12 that increasing collagen matrix stiffness is sufficient to drive the nuclear accumulation of YAP in NFs (Fig. 6g ). The data above establish a link between the contractile cytoskeleton, matrix stiffness and YAP activity. However these phenomena could be linked in a number of different, but not mutually exclusive, ways. Actomyosin function could simply be required to generate a stiff ECM, but not to respond to it. Similarly, the contractile actin network might be required for sensing of matrix rigidity. To explicitly test the latter hypothesis, we allowed CAFs three days to remodel the collagen-rich matrix and then acutely treated with inhibitors ( Fig. 7a) . These experiments reveal that ROCK, myosin Supplementary  Table S2 (Statistics Source Data). Uncropped images of blots are shown in Supplementary Fig. S6 .
and Src function (blocked by PP2 and dasatinib) are required to maintain the nuclear localization of YAP in CAFs, even after the ECM has been remodelled. Consistent with this, treatment of mice with Y27632 reduced the nuclear localization of YAP in CAFs, and prevented the CAFs from promoting angiogenesis (Fig. 7b,c) . Examination of cell morphology revealed that ROCK inhibition disrupted contractile stress fibres, whereas Src inhibition did not ( Supplementary Fig. S5d ). Further, ROCK inhibition reduced Src activity ( Supplementary Fig. S5e ). Thus, we propose that Src acts downstream 43 from cytoskeletal tension to regulate YAP. Inhibition of ROCK and Src did not affect phosphorylation of MST1/2 and S127-YAP ( Supplementary Fig. S5e ). However, blebbistatin, Y27632 and dasatinib all reduced the association of YAP with TEAD1 and TEAD4, but increased its association with 14-3-3 proteins (Fig. 7d ). Together, these data suggest that matrix stiffness promotes actomyosin-dependent regulation of Src-family kinases leading to a switching of YAP away from binding 14-3-3 proteins in favour of association with TEAD1 and TEAD4. This change does not seem to be linked to changes in MST activity or S127-YAP phosphorylation ( Fig. 2c and Supplementary Fig. S5e ). YAP is required for elevated levels of MYL9 and MYH10 and matrix stiffening by CAFs (Fig. 5 ). Conversely, stiff matrices and the contractile actin cytoskeleton work together to activate YAP (Fig. 6 ). Together these elements generate a positive feedback loop. Depending on the level of damping, this loop of matrix stiffening and YAP activation might be able to be broken by inhibition of the loop for a period of time. We explored this hypothesis by culturing CAFs in the presence of Y27632 for a prolonged period and then assayed their phenotype after removal of the inhibitor. Figure 7e shows that Y27632 effectively reduced matrix remodelling when included during the assay. More notably, cells that had previously been cultured in Y27632, but were assayed in normal media, showed significantly defective matrix remodelling abilities 3-5 days after removal of the drug (Fig. 6l ). This demonstrates that if the feed-forward loop between the matrix and YAP can be blocked, then a stable reversion in cell behaviour arises.
DISCUSSION
Here we demonstrate a new role for the YAP oncoprotein in the tumour stroma. YAP function is critical for the establishment and maintenance of CAFs. We propose that soluble factors secreted by cancer cells initially promote an intermediate level of YAP and TAZ activity 44, 45 . YAP activation occurs as a consequence of two inter-related events: first, the matrix remodelling and stiffening induced by factors such as LPA and TGF-β, and, second, changes in the contractile actin cytoskeleton within fibroblasts. Stiff matrices require actomyosin function for their generation; however they also enable actomyosin to generate isometric tension within cells (Fig. 7) . This leads to stress fibre formation, and the activation of Src-family kinases at focal adhesions 46 . Src-family kinase function is required for YAP activity. YAP function is required for the expression of MYL9, matrix stiffening and many pro-tumorigenic properties of fibroblasts. The matrix stiffening resulting from YAP activation generates a positive feedback loop, leading to the more robust and sustained activation of the YAP pathway observed in CAFs. Once this feedback is established it can become self-sustaining, and this could explain the stability of the CAF phenotype in the absence of co-culture with cancer cells. In vivo, it is likely that this mechanism cooperates with epigenetic changes induced by soluble factors in the tumour micro-environment. It is also possible that YAP activation could be initiated by soluble factors in the absence of cancer cells; these may act by triggering matrix stiffening or through more direct G-protein-coupled receptor signalling to YAP (ref. 44 ). It will be interesting to determine whether YAP plays a role in matrix stiffening in pre-cancerous lesions or, more generally, in fibrosis. YAP-dependent matrix stiffening driven by CAFs may also lead to pro-tumorigenic YAP activation in cancer cells in close proximity to the stiff matrix. Consistent with this, we and others have noted high levels of nuclear YAP in cancer cells adjacent to the stroma 13 . Similarly, matrix stiffening may lead to the propagation of YAP activity to nearby normal fibroblasts. To conclude, we identify a key role for YAP in the tumour stroma. It is required for many of the pro-tumorigenic functions of CAFs, including matrix stiffening, invasion and angiogenesis. High levels of YAP function in the stroma are sustained through positive feedback between CAF-driven matrix stiffening and mechanotransduction leading to YAP activation.
METHODS
Methods and any associated references are available in the online version of the paper. 
Isolation and immortalization of fibroblasts from different tumoral stages.
Normal mammary glands, hyperplastic mammary tissue (generally from 6-week-old females), mammary adenoma/early carcinoma tissue (from 8-to 10-week-old females) and mammary carcinoma/late carcinoma/invasive carcinoma tissue (older than 12 weeks) were dissected out and part taken for histological analysis and part for fibroblast isolation. Two approaches were followed for fibroblast isolation. To isolate fibroblasts from normal tissue, which is very soft and fatty, we placed the tissue into dishes where it was compressed under a 20 mm coverslip to prevent fatty tissue floating. We then covered it with DMEM (Invitrogen) with 10% FCS (PAA Labs) and 1% ITS (insulin-transferrin-selenium; #41400-045; Invitrogen) supplement and changed the media daily. After 7-10 days, fibroblasts started to grow out of the tissue into the coverslip and the dish. Then, the tissue was removed and the fibroblast population expanded. For hyperplastic, adenomal and cancerous tissue, the sample was cut into small pieces and collagenase/dispase digested. After filtering the undigested tissue, the solution was serial centrifuged and the final pellet re-suspended in DMEM (Invitrogen) with 10% FBS and 1% ITS and seeded on a culture dish. After 30 min the fibroblasts had already adhered to the dish whereas other cellular types remained in suspension. In both cases, fibroblasts were subsequently grown and immortalized with HPV-E6 retrovirus 20 . They were then selected using 2.5 µg ml −1 puromycin.
Clinical samples and human CAFs.
The tumour specimens and tissue samples used in this study were obtained with informed consent from all subjects. Human SCC CAFs were isolated following similar approaches to murine CAFs and were grown and immortalized with htert lentivirus. They were selected using 400 µg ml −1 hygromycin.
Histochemical analysis. Frozen tumours were embedded in OCT and sections 6-8 µm were cut. These sections were then fixed in 4% paraformaldehyde and stained using the same protocols for immunofluorescence microscopy of cultured cells (see below). Tissue fixed in 10% formal saline was paraffin embedded and sectioned using standard methods. In addition to haematoxylin and eosin staining and Masson's trichrome staining, the antibodies used are listed in Supplementary  Table S3 . Breast cancer tissue arrays were from Biomax (References: BR802 and BR243f).
Immunofluorescence microscopy. Unless stated otherwise, all immunofluorescence microscopy experiments were performed on cells seeded on the top of a thin layer of a mixture of collagen I (#354249; BD Biosciences) and Matrigel (#354234; BD Biosciences) yielding a final collagen concentration of approximately 4.6 mg ml −1 and a final Matrigel concentration of approximately 2.2 mg ml −1 (collagen I/Matrigel matrix hereafter). After 2 days on the gel and the pertinent treatments, cells were fixed in 4% paraformaldehyde for 1 h. Cells were permeabilized by incubation in PBS 0.5% NP-40 (Sigma) at 4 • C for 20 min (twice), in PBS with 0.3% Triton X-100 (Sigma) at room temperature for 20 min and in PBS with 0.1% Triton X-100 at room temperature for 15 min (twice). Samples were blocked for 60 min at room temperature (twice) in blocking solution: 4% BSA in PBS with 0.05% Tween20 (Sigma). Then, cells were incubated with primary antibody in blocking solution in a wet chamber overnight at 4 • C. After 3 washes of 15 min in PBS, secondary antibody in blocking solution was added. After 3 washes of 15 min in PBS, samples were mounted and analysed using an inverted Zeiss LSM780. Antibody description and working dilutions can be found in Supplementary Table S3 . To quantify YAP or TAZ nuclear localization, a measure of their activation, two approaches were employed. In the first, we calculated the percentage of cells with a clear predominant nuclear staining among the total cell number (cells with nuclear staining, cells with cytosolic staining and cells with homogeneous nuclear/cytosolic staining), counting at least 300 cells in triplicate. For the second, photographs were processed using Volocity. Briefly, we calculated for each cell the nuclear YAP/TAZ intensity (determined by the intensity within the region delimited by DAPI staining) and the cytosolic YAP/TAZ intensity (determined by the intensity without the region delimited by DAPI staining and within the region delimited by F-actin staining) for at least 25 cells in triplicate. Plots represent the ratio of nuclear versus cytosolic YAP or TAZ staining. Quantitative analysis of images of CAF markers was performed using MATLAB software. Briefly, fibroblasts were identified using an automated threshold based on F-actin staining. The mean intensities of αSMA, S100A4 and FAP were then measured.
Western blotting. Unless stated otherwise, all protein lysates were obtained from cells seeded on top of a thin layer of a mixture of collagen I/Matrigel matrices. Generally, 100 µl of the gel was spread evenly on a 6-well-plate dish. Apart from that, protein lysates were processed following standard procedures. Antibody description and working dilutions used can be found in Supplementary Table S3 .
Immunoprecipitation. Endogenous YAP immunoprecipitations were performed as described previously 47 . Briefly, cells were lysed in 50 mM Tris (pH 8), 100 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM MgCl 2 , 2 mM phenylmethyl sulphonyl fluoride, and protease and phosphatase inhibitors. The supernatants were pre-cleared by incubating for 30 min at 4 • C with protein-G beads. Supernatants were incubated with anti-YAP antibodies and protein-G beads overnight. Immunoprecipitates were washed three times with NET buffer (50 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.25% gelatine and 0.1% Nonidet P-40) and analysed by immunoblotting. Exposures within the dynamic range were quantified by densitometry using the program NIH Image 1.60.
ECM-remodelling assay. To assess force-mediated matrix remodelling, 75 × 10 3 fibroblasts were embedded in 100 µl of collagen I/Matrigel and seeded on a 35-mm glass-bottom MatTek dish (P35-1.5-14-C, MatTek). Once the gel was set, cells were maintained in DMEM + 10% FCS (unless otherwise stated) + 1% ITS. Gel contraction was monitored daily by taking photographs of the gels. Unless stated otherwise, the gel contraction value refers to the contraction observed after 3 days. To obtain the gel contraction value, the relative diameters of the well and the gel were measured using ImageJ software, and the percentage of contraction was calculated using the formula 100× (well diameter − gel diameter)/well diameter.
Atomic force microscopy. To assess the elastic modulus of gels remodelled by fibroblasts, 75 × 10 3 fibroblasts were embedded in 100 µl of collagen I/Matrigel and seeded on an ultralow-attachment 96-well plate well (#3474, Costar). Once the gel was set, cells were maintained in DMEM + 10% FCS + 1% ITS. After 3 days, the elastic modulus of the gels was measured. On the day of the experiment, gels were gently lifted from their well and fixed in the centre of 50-mm glass-bottom Petri dishes using cyanoacrylate superglue. Once glued, Leibovitz L-15 medium (Invitrogen) supplemented with 10% FCS was added to the dish.
Atomic force microscopy (AFM) measurements were performed with a JPK Nanowizard-I (JPK instruments) interfaced to an inverted optical microscope (IX-81, Olympus). AFM cantilevers with pyramidal tips (MLCT, Bruker) and nominal spring constants of 0.07 Nm −1 were modified by gluing 35-µm-radius glass beads to the cantilever underside with ultraviolet curing glue (ultraviolet curing, Loctite). Cantilever spring constants were determined before modification using the thermal noise method implemented in the AFM software (JPK SPM).
Before any indentation tests, the sensitivity of the cantilever was set by measuring the slope of force-distance curves acquired on glass regions of the Petri dish. Using the optical microscope, the tip of the cantilever was aligned over regions in the middle of the gel and, for each gel, measurements were acquired in 30-40 locations ∼100 µm apart. Force-distance curves were acquired with an approach speed of 5 µm s −1 until reaching the maximum set force of 3 nN. After the experiment, the elastic moduli were extracted from the force-distance curves by fitting the contact portion of curves to a Hertz contact model 48 . For each force-distance curve, goodness of fit was evaluated by calculating r 2 values and only fits with r 2 > 0.80 were retained for further analyses (representing on average 80% of the acquired force curves).
Invasion assays. The human CAF organotypic culture system was set up as previously described 6 . The mouse mammary CAF organotypic culture system was set up with some adaptations. Briefly, 10 6 fibroblasts, unless stated otherwise, were embedded in a mixture of collagen I/Matrigel matrix. After the gel was set at 37 • C for 1 h, DMEM + 10% FCS + 1% ITS was added on the top. Sixteen hours later, 5 × 10 5 4T1/410.4/TS2 cells were seeded on top in DMEM + 10% FCS + 1% ITS. After 8 h, a thin layer of gel was added covering the breast cancer cells. The gel was then mounted on a metal bridge and fed from underneath with DMEM + 10% FCS + 1% ITS (changed daily). After 6 days, the cultures were fixed using 4% paraformaldehyde plus 0.25% glutaraldehyde in PBS and processed by standard methods for haematoxylin and eosin staining. For assays involving the removal of fibroblasts (fibroblast-conditioned ECMs), the fibroblasts were left to remodel the gel for 5 days, after which the gels were incubated in DMEM + 10% FCS + 1% ITS plus hygromycin (400 µg ml −1 ) for 48 h to kill the fibroblasts and then washed three times with DMEM + 10% FCS + 1% ITS (>30 min per wash). Then, 5 × 10 5 410.4/4T1 cells were plated on top and the assays proceeded as usual. The invasion index was calculated by measuring the total area over which breast cancer cells had dispersed (including invading and non-invading cells) and the area of non-invading cells. The value shown is the average of the measurement (1 − (non-invading DOI: 10.1038/ncb2756 area/total area)) of at least ten measurements from two or more independent experiments and the error bars represent the s.e.m. MATLAB script was used to automatically identify the total cell area and the non-invading area. The M files are available on request, email robert.jenkins@cancer.org.uk.
Matrigel plugs. Fibroblasts (2×10 6 ) were resuspended in 100 µl of PBS and mixed in 300 µ l of Matrigel. Then, 300 µl of the mixture was injected subcutaneously on the mammary fat pad of a 12-week-old FVB/n female. After 7 days, the plugs were surgically removed and taken for histological and immunofluorescence microscopy analyses. Blood vessel density was calculated by normalizing the area positive for endomucin staining to the area positive for vimentin staining of all the slices processed. Each value in the plot corresponds to the blood vessel density of an individual plug.
RNA isolation and arrays. To obtain RNA from the different fibroblast populations, cells were seeded on top of the collagen I/Matrigel matrix and fed with complete media. After 5 days, RNA was isolated using RNeasy Kit (#74104, Qiagen). RNA was then processed in collaboration with the Bart's and London Centre for Genome Research (Illumina bead array platform-details available on request).
GSEA. Array data were processed and analysed using the GSEA software, developed by the Broad Institute of MIT and Harvard (USA) and available at www. broadinstitute.org, following the program guidelines. The specific settings applied in all analyses are: number of permutations (1,000), permutation type (gene set), enrichment statistic (weighted), metric for ranking genes (t -test). The rest of the fields were left as defaulted. Values in the tables represent the nominal P value of each gene set. A list of the specific gene sets analysed and their sources is available in Supplementary Table S4 . For further references to the gene sets, see refs 49-56. Interleukin and RANKL gene sets were obtained from www.netpath.org.
Quantitative real-time PCR.
Sequences of the oligonucleotides used are described in Supplementary Table S5 .
Statistical analyses. Statistical analyses were performed using Prism software (GraphPad Software). Mean values and standard errors (s.e.m.) are shown in most graphs that were generated from several repeats of biological experiments. P values were obtained from t -tests with paired or unpaired samples, with significance set at P < 0.05. Graphs show either the actual P value or symbols describing it ( * ,P < 0.05; * * ,P < 0.01; * * * ,P < 0.001). Source data for the indicated figures can be found in Supplementary Table S2 .
Transfections, inhibitors, siRNA and cDNAs. Fibroblasts were cultured in standard conditions and transfected using DharmaFECT 1 (#T-2001-03; Dharmacon, Perbio Science). Briefly, cells were plated at 60% confluence and subjected to transfection the following day using 100 nM final concentration of siRNA. siRNA was purchased from Dharmacon and sequences are listed in Supplementary Table  S6 . The following growth factors and drugs were used: TGF-β, 2 ng ml −1 (Pepro-Tech); LPA, 2 µg ml −1 (L7260, Sigma); Y27632, 10 µM (#1254; Tocris Bioscience); blebbistatin, 25 µm (#203391; Calbiochem/Merck); dasatinib, 300 nM (LCLabs); and PP2, 10 µM (Calbiochem/Merck). Conditioned medium from 4T1 cells was obtained by conditioning plain DMEM in a 75% confluent culture for 24-48 h. pEGFP-MYL9 wild-type and pEGFP-MYL9 T18A, S19A (TASA) mutant were a gift from M. Olson (Beatson Institute, Glasgow, UK D) Left hand panel shows double immune-fluorescence for αSMA (red) and Fibronectin (green) with DAPI shown in blue. Scale bar is 100µm. Mid-left panel shows triple immune-fluorescence for αSMA (red), S100A4 (green), and FAP (blue) in tumour section. White arrows indicate αSMA and S100A4 double positive cells, red arrows indicate αSMA positive/S100A4 negative cells, and green arrow indicates S100A4 positive/αSMA negative cell. Scale bar is 50µm. Mid-right and right hand panels show the same staining on CAF#1 and CAF#2 cultured in vitro. E) Charts indicate the expression of αSMA, FAP and S100A4 in the three human SCC CAF isolate -CerCAF -cervical SCC, HNCAF -head and neck SCC, and VCAF -Vulval SCC. Data from one representative experiment from a total of 2 are shown. Each point represents quantification of an individual cell. Line and error bars indicate mean ± s.d. of the population. Thus the plots illustrate both the mean level and heterogeneity in marker expression in each CAF isolate. CerCAF, HNCAF, and VCAF have different αSMA expression, VCAF have different FAP expression from other CAFs and CerCAF have different S100A4 expression from other CAFs.* P < 0.05; ** P < 0.01; *** P < 0.001 -ANOVA. F) Chart summarises the average level of expression of different markers in the seven CAF isolates used in this study. 
Blots from Figure 1
